440099-01-4

Basic information

• Product Name: 2-[1-(3,4-Dimethoxy-benzyl)-7,8-dimethoxy-1,3,4,5-tetrahydro-benzo[c]azepin-2-yl]-N-(2-methylsulfanyl-ethyl)-2-phenyl-acetamide
• CAS NO: 440099-01-4
• Molecular Weight: 564.746
• Mol File: 440099-01-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-[1-(3,4-Dimethoxy-benzyl)-7,8-dimethoxy-1,3,4,5-tetrahydro-benzo[c]azepin-2-yl]-N-(2-methylsulfanyl-ethyl)-2-phenyl-acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[1-(3,4-Dimethoxy-benzyl)-7,8-dimethoxy-1,3,4,5-tetrahydro-benzo[c]azepin-2-yl]-N-(2-methylsulfanyl-ethyl)-2-phenyl-acetamide(440099-01-4)
• EPA Substance Registry System: 2-[1-(3,4-Dimethoxy-benzyl)-7,8-dimethoxy-1,3,4,5-tetrahydro-benzo[c]azepin-2-yl]-N-(2-methylsulfanyl-ethyl)-2-phenyl-acetamide(440099-01-4)

Safety Data

• Hazardous Substances Data: 440099-01-4(Hazardous Substances Data)

Upstream product

• 439933-59-2 [1-(3,4-Dimethoxy-benzyl)-7,8-dimethoxy-1,3,4,5-tetrahydro-benzo[c]azepin-2-yl]-phenyl-acetic acid 
• 18542-42-2 (2-aminoethyl)methylsulfide 

Relevant articles and documents

Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists

The invention relates to novel benzazepines and related heterocyclic derivatives (I) and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as orexin receptor antagonists.